You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
21 August 2018 - Oncology company OncoTracker Inc revealed on Monday the election of James Kuo, MD, MBA as its chief executive officer.Most recently, Dr Kuo has served as managing director at Athena Bioventures.Previously, Dr Kuo has worked as chairm...
21 August 2018 - Biotechnology company Q BioMed Inc (OTCQB:QBIO) (OtherOTC:QBIO) said on Monday that it has submitted its supplemental regulatory filing with the US FDA for the approval of a new facility for the manufacture of Strontium Chloride Sr89...
21 August 2018 - Global healthcare company Novo Nordisk A/S (CPH:NOVOB) reported on Monday the headline results from PIONEER 5, a phase 3a trial with oral semaglutide in adults with type 2 diabetes and moderate renal impairment.Oral semaglutide is an...
21 August 2018 - United States-based AbbVie has signed a clinical research collaboration agreement with United States-based Tolero Pharmaceuticals.It was reported yesterday that the collaboration is aimed at assessing the potential benefits of veneto...
21 August 2018 - Immunocore, a T Cell Receptor biotechnology company, has dosed the first patient in a phase I study of IMCnyeso, an ImmTAC molecule, as part of a collaboration with United Kingdom-based GlaxoSmithKline (GSK), it was reported yesterda...
21 August 2018 - United States-based Bristol-Myers Squibb has received US Food and Drug Administration (FDA) approval for its Opdivo as the first and only immuno-oncology treatment option for patients with metastatic small cell lung cancer (SCLC) who...
21 August 2018 - Life sciences company IsoPlexis Corporation (IsoPlexis) said on Monday that it plans to distribute its single-cell proteomic analysis platform products in China's pharmaceutical and life sciences markets through an exclusive agr...